Occlusion Devices Market Scope And Analysis

  • Report Code : TIPRE00039110
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Occlusion Devices Market Analysis and Growth - 2031

Buy Now

Occlusion Devices Market Report Occlusion Devices Market Size and Share Occlusion Devices Market Scope and Analysis

Occlusion Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 8.90 Billion
Market Size by 2031 US$ 31.71 Billion
Global CAGR (2023 - 2031) 17.2%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Product
  • Occlusion Removal Devices
  • Embolization Devices
  • Support Devices
By Application
  • Neurology
  • Cardiology
  • Peripheral Vascular Diseases
  • Urology
  • Oncology
  • Gynecology
By End User
  • Hospitals
  • Diagnostic Centers & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Boston Scientific Corporation
  • LeMaitre Vascular Inc
  • Edwards Lifesciences Corporation
  • Medtronic
  • MicroPort Scientific Corporation
  • Johnson Johnson
  • Terumo Group
  • Stryker Corporation

    • Industry Developments and Future Opportunities:

    A few of the strategic developments by leading players operating in the occlusion devices market, as per company press releases, are listed below:

    • In February 2024, BIOTRONIK and Interventional Medical Device Solutions (IMDS) partnered to launch an innovative Micro Rx catheter. It is a rapid exchange microcatheter designed to enhance guidewire support during percutaneous coronary interventions (PCI). This advanced device is exclusively distributed by BIOTRONIK and manufactured by IMDS.

    In September 2023, MicroPort Endovastec announced the successful implantation of the Reewarm PTX Drug Coated Balloon (DCB) Catheter by a team of doctors at Paulo Sacramento Hospital in Sao Paulo, Brazil. This shows the product’s continued proliferation in international markets. This device is intended to treat stenosis or occlusion in the femoral-popliteal artery for percutaneous transluminal angioplasty (PTA) in the peripheral vessels.

    Competitive Landscape and Key Companies:

    Abbott; Boston Scientific Corporation; LeMaitre Vascular, Inc; Edwards Lifesciences Corporation; Medtronic; MicroPort Scientific Corporation; Johnson & Johnson; Terumo Group; Stryker Corporation; and Tokai Medical Products are among the prominent companies profiled in the occlusion devices market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.